日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Progressive resistance training in a post-acute, older, inpatient setting: A randomised controlled feasibility study

在老年住院康复期患者中开展渐进式阻力训练：一项随机对照可行性研究

期刊:Journal of Frailty Sarcopenia and Falls
影响因子:
doi:10.22540/JFSF-06-014
Coleman, Sinéad A; Cunningham, Conal J; Murphy, Niamh; Feaheny, Jean; Robinson, David; Lannon, Rosaleen; McCarroll, Kevin; Casey, Miriam; Harbison, Joseph; Horgan, N Frances
发表日期：2021
文献求助 收藏

The EXERRT trial: "EXErcise to Regadenoson in Recovery Trial": A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson without exercise for myocardial perfusion imaging using a SPECT protocol

EXERRT试验：“运动后使用雷加德诺松进行恢复试验”：一项3b期、开放标签、平行组、随机、多中心研究，旨在评估运动负荷试验结果不理想后使用雷加德诺松与不运动时使用雷加德诺松进行SPECT心肌灌注显像的效果。

期刊:Journal of Nuclear Cardiology
影响因子:2.7
doi:10.1007/s12350-017-0813-3
Thomas, Gregory S; Cullom, S James; Kitt, Therese M; Feaheny, Kathleen M; Ananthasubramaniam, Karthikeyan; Gropler, Robert J; Jain, Diwakar; Thompson, Randall C
发表日期：2017
文献求助 收藏

A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease

一项随机、双盲、安慰剂对照研究，旨在评估雷加德诺松在哮喘或慢性阻塞性肺疾病患者中的安全性和耐受性。

期刊:Journal of Nuclear Cardiology
影响因子:2.7
doi:10.1007/s12350-012-9547-4
Prenner, Bruce M; Bukofzer, Stan; Behm, Sarah; Feaheny, Kathleen; McNutt, Bruce E
哮喘
慢性阻塞性肺疾病
发表日期：2012
文献求助 收藏

A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease

一项随机、双盲、安慰剂对照研究，旨在评估雷加德诺松在3期或4期慢性肾脏病患者中的安全性和耐受性。

期刊:Journal of Nuclear Cardiology
影响因子:2.7
doi:10.1007/s12350-011-9508-3
Ananthasubramaniam, Karthik; Weiss, Robert; McNutt, Bruce; Klauke, Barbara; Feaheny, Kathleen; Bukofzer, Stan
发表日期：2012
文献求助 收藏